Trading Signals: EDIT Stock Price Prediction and Forecast (Wed. Feb. 3, 2016 - Fri. Dec. 22, 2023)(EDITAS MEDICIN)
| EDIT latest price $9.2800 (-19.23%) ($9.2200 - $10.1900) on Thu. Jun. 15, 2023. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 5.71% (three month average) | RSI | 52 | Latest Price | $9.2800(-19.23%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | EDIT declines -2.6% a day on average for past five trading days. | Weekly Trend | EDIT advances 4.2% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support EDIT advance at 0% a week (0% probability) XBI(63%) IBB(49%) IWC(48%) IWM(45%) IWO(45%) | Factors Impacting EDIT price | EDIT will decline at least -2.855% in a week (0% probabilities). IGOV(-16%) TBT(-12%) UNG(-7%) UUP(-6%) VXX(-5%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.855% (StdDev 5.71%) | Hourly BBV | 0 () | Intraday Trend | -8.4% | | | |
|
Resistance Level | $9.66 | 5 Day Moving Average | $9.99(-7.11%) | 10 Day Moving Average | $9.96(-6.83%) | 20 Day Moving Average | $9.66(-3.93%) | To recent high | -19.2% | To recent low | 46% | Market Cap | $576m | | | | Editas Medicine, Inc. engages in the development and commercialization of genome editing technology. Its technology includes clustered, regularly interspaced short palindromic repeats (CRISPR), and CRISPR associated protein 9 (Cas9). The company was founded by Feng Zhang, Jennifer A. Doudna, George McDonald Church, J. Keith Joung and David R. Liu in September 2013 and is headquartered in Cambridge, MA. |